Avalon Consulting

Views on Tesla’s Entry Into India

Avalon Consulting — Mon, 08 Sep 2025 03:08:07 +0000

Subhabrata Sengupta, Partner at Avalon Consulting, shares his perspective on Tesla’s much-awaited entry into India. He highlights the opportunities in accelerating EV adoption, creating a stronger local supply chain, and shaping policies for clean mobility. While India presents challenges in infrastructure and affordability, Tesla’s move could catalyse rapid transformation in the automotive sector. This milestone signals a pivotal moment in India’s journey toward sustainable transportation.

Taking too long?

Reload document

| Open in new tab

Taking too long?

Reload document

| Open in new tab

The post Views on Tesla’s Entry Into India appeared first on Avalon Consulting.

India- UK FTA & its after effects on Textile Sector

Avalon Consulting — Thu, 04 Sep 2025 10:23:04 +0000

Premchand Chandrasekharan, Partner at Avalon Consulting, shared his quotes on India- UK FTA & its after effects on Textile Sector, which was published in BW Businessworld. He highlighted that Indian MSMEs must overcome gaps in scale, technology, and compliance, with tailored support for each segment to unlock UK opportunities.

India’s Russia Oil Dilemma as Trump Courts Pakistan with Energy Pact

Avalon Consulting — Thu, 04 Sep 2025 02:54:45 +0000

Himanshu Trivedi, Associate Vice President at Avalon Consulting, shared his views on India’s Russia Oil Dilemma as Trump Courts Pakistan with Energy Pact, published in Outlook Business

He pointed out that the talk of massive oil reserves in Pakistan is not supported by facts, as the country still produces very little and depends heavily on imports.

He added that such claims appear more political in nature than a real energy opportunity.

Tesla Dares BYD & BMW in India’s Luxury EV Lane: Competition and Ecosystem Impacts

Avalon Consulting — Tue, 26 Aug 2025 14:57:54 +0000

Subhabrata Sengupta, Partner at Avalon Consulting, shared that Tesla’s entry into India’s premium EV market will intensify competition with established players like BMW and BYD, expanding consumer choice and fostering segment growth.

The article can be found here:

https://www.livemint.com/news/tesla-byd-bmw-merc-indias-luxury-lane-mumbai-delhi-gurugram-model-y-ev-mercedes-benz-luxury-tax-tariff-11752571667710.html

The Tesla brand is expected to accelerate EV adoption, supported by investments in charging infrastructure and heightened market excitement.

Taking too long?

Reload document

| Open in new tab

Taking too long?

Reload document

| Open in new tab

The post Tesla Dares BYD & BMW in India’s Luxury EV Lane: Competition and Ecosystem Impacts appeared first on Avalon Consulting.

Entrepreneurs Driving Change: Voices on World Entrepreneur’s Day 2025

Avalon Consulting — Thu, 21 Aug 2025 12:34:41 +0000

Vivek Prasad, Executive Director at Avalon Consulting, shares how entrepreneurship has been democratized by technology and social media. The key, however, remains in solving real-world problems with simplicity, efficiency, and a focus on sustainable unit economics.

Taking too long?

Reload document

| Open in new tab

The post Entrepreneurs Driving Change: Voices on World Entrepreneur’s Day 2025 appeared first on Avalon Consulting.

Agribiz Connect 2025: Unlocking the Agriculture and Food Processing Business Potential

Avalon Consulting — Thu, 21 Aug 2025 06:01:25 +0000

Proud moment for Avalon Consulting at Agribiz Connect 2025!

Santosh Sreedhar, Partner at Avalon, was invited to speak at the Southern Regional Summit organized by ASSOCHAM in Hyderabad.

As part of the conference, Santosh unveiled a white paper authored by the Avalon team, outlining the full potential of Telangana’s agriculture and food processing sector.

He also contributed to thought-provoking discussions on “Farm to Factory: Unlocking Value in Agro-processing” and moderated a panel on “Advancing global partnerships for Agricultural Development”, reinforcing Avalon’s commitment to shaping the future of agribusiness.

The post Agribiz Connect 2025: Unlocking the Agriculture and Food Processing Business Potential appeared first on Avalon Consulting.

Review of Proposed GST Exemption on Health and Life Insurance Products

Avalon Consulting — Thu, 21 Aug 2025 02:56:09 +0000

Ayush Patodia, Associate Vice President at Avalon Consulting, shared his views on the Proposed GST Exemption on Health and Life Insurance Products, which was published in The Economic Times.

He discussed how exempting health and life insurance from GST could expand coverage for underserved groups and push insurers toward leaner, more digital, and inclusive models

New age luggage brands that are disrupting the category challenging players like VIP Samsonite Safari

Avalon Consulting — Mon, 04 Aug 2025 13:19:54 +0000

Vivek Prasad, Executive Director at Avalon Consulting, shared his insights on new-age luggage brands that are disrupting the market and challenging established players, which was featured in BrandWagon FinancialExpress.

He emphasized that well-established brands need to refresh their product lines, leverage digital marketing strategies, and diversify their offerings beyond just trolleys to remain competitive against these emerging players.

Impact Paper 32: Supporting the IPO Journey of a Tech-Enabled Diversified Auto Industry Player

Avalon Consulting — Thu, 31 Jul 2025 06:31:37 +0000

Avalon Consulting supported a leading, diversified automotive solutions provider in its successful IPO journey. Facing challenges due to complex business segments, Avalon validated the client’s growth strategy, developed robust business and financial plans, and created comprehensive investor communications, including DRHP and multiple pitch decks. The intervention ensured timely IPO filing, effective resolution of regulator queries, and eventual approval, laying a strong foundation for long-term value creation.

Download Article [555 KB]

Taking too long?

Reload document

| Open in new tab

The post Impact Paper 32: Supporting the IPO Journey of a Tech-Enabled Diversified Auto Industry Player appeared first on Avalon Consulting.

When Pills Can Talk: How IOT is Revolutionizing Pharma from Factory to Patient

Parul Gupta — Mon, 21 Jul 2025 09:37:56 +0000

Parul Gupta and Utpal Kaushik, Consultants at Avalon Consulting, co-authored an article on How IOT is Revolutionising Pharma from Factory to Patient, which was published in EM-Efficient Manufacturing. They discussed how IoT is transforming the pharmaceutical industry by enabling end-to-end traceability and real-time monitoring, from manufacturing on the factory floor to patient adherence. They emphasized that “smart” pills and connected devices are revolutionizing safety, supply-chain transparency, and therapeutic outcomes.

In December of 2020, when the world was locked down to prevent the spread of a virus causing Severe acute respiratory syndrome, Pfizer faced a nearly impossible challenge—deliver millions of ultra-cold COVID-19 vaccines across the globe with zero margin for error. In the past, manual temperature checks and paper logs might have left critical blind spots. But this time, things were different. IoT-enabled thermal shipping boxes, equipped with sensors, tracked the temperature and location in real-time. As vaccines moved through a vast, complex distribution network, every deviation was flagged instantly, every alert routed to a centralized dashboard. The result? 99.9% integrity maintained — millions of lives protected.

This is just one example of how the Internet of Things (IoT) is reshaping pharmaceuticals into a responsive, intelligent, and deeply interconnected ecosystem. Sensors in factories, smart labels on packages, wearables on patients—all these devices are now nodes in a vast, digital nervous system. From production to packaging, and from logistics to patient care, IoT is turning reactive systems into proactive ones. Companies like Johnson & Johnson have adopted continuous manufacturing through embedded sensors, streamlining production and slashing batch release times from weeks to mere hours. Merck’s use of AI-integrated sensors has cut vaccine discard rates by detecting process bottlenecks early. Novartis, AstraZeneca, Moderna—the list of pharma giants transforming their operations with IoT grows by the day.

At its core, IoT is a network of physical devices—sensors, trackers, machines, even pill bottles—connected to the internet and capable of exchanging real-time data. In the pharmaceutical context, it means machines that report their status, shipments that broadcast their location and condition, and wearables that share biometric data without delay. These devices form a feedback loop that allows companies to respond instantly, whether that’s fixing a faulty machine, rerouting a delayed shipment, or alerting a doctor to a patient’s health change.

Figure 1: IoT in Action

The need for this transformation is rooted in the past. Pharma, for decades, operated through slow, manual processes. Imagine a factory where quality control involved paper logs and random sampling, missing micro-defects in drug batches. Or consider vaccine shipments where temperature deviations during transit were discovered only after reaching their destination—often too late. In clinical trials, researchers relied on self-reported symptoms and infrequent visits, limiting data quality and participant reach. All this led to high costs, regulatory setbacks, and even drug recalls. Now, sensors embedded in equipment and packages transmit real-time data to AI-powered systems that adjust parameters automatically or trigger alerts. Remote patient monitoring through wearables allows decentralized trials with higher retention, better diversity, and faster insights. AstraZeneca’s decentralized trials, for instance, have cut dropout rates by 35% while enhancing patient engagement.

Smart wearables are pushing this evolution further into the hands—and onto the wrists—of everyday people. Imagine a watch that doesn’t just tell time—it could save your life. Apple Watches today detect falls and can alert emergency services if there’s no response. Fitness trackers monitor heart rate variability, sleep, and oxygen levels, offering early warnings for potential issues. Diabetic patients use discreet, skin-worn glucose monitors that transmit blood sugar data in real-time to their phones. These aren’t just consumer electronics; they’re healthcare enablers, empowering patients and giving doctors access to a stream of accurate, timely data that can inform treatment.

IoT is also making pharmaceuticals safer and more trustworthy. By combining IoT with blockchain, companies are building transparent supply chains where every product’s journey is traceable and tamper-proof. Boehringer Ingelheim’s AI-powered vision systems scan for packaging defects with higher accuracy than any human inspector. Moderna’s use of digital twins and real-time monitoring has slashed quality deviations by over a third. Even energy and resource use are optimized through IoT, helping the industry meet sustainability goals without compromising quality or speed.

This blend of IoT and pharma is enabling better health outcomes on a global scale. Faster development cycles, safer supply chains, and more personalized care models are no longer future promises—they’re happening now. The pharma sector, once characterized by paperwork and guesswork, is transforming into one where data flows uninterrupted and decisions are made in real time. For patients, it means earlier interventions and more effective treatments. For the industry, it means fewer recalls, faster approvals, and stronger trust with regulators and the public.

Figure 2: Leveraging IoT in Patient Treatment and Monitoring

Of course, challenges remain. Data security, legacy system integration, and upfront implementation costs are all valid concerns. But the direction is clear. As the infrastructure matures and expertise spreads, the barriers will continue to fall.

IoT isn’t just a tool—it’s the foundation of a smarter, safer, more responsive pharmaceutical industry. And as companies continue to innovate, the ultimate beneficiaries will be the people: patients receiving better care, faster; families protected from disease; and healthcare systems that can finally shift from reactive to preventive. The future of medicine isn’t just digital. It’s connected.

The post When Pills Can Talk: How IOT is Revolutionizing Pharma from Factory to Patient appeared first on Avalon Consulting.

ABS rollout deadline may trigger import spike but timeline likely to see relaxation

Avalon Consulting — Sun, 20 Jul 2025 08:22:08 +0000

Subhabrata Sengupta, Partner at Avalon Consulting, shared his insights on ABS Rollout Deadline and its impact on Imports, which was published in Mint.

He noted that ABS production in India will expand as players localize quickly, though deadlines may see slight extensions to ensure smoother implementation.

Impact Paper 31: Unlocking synergies for a leading FMEG company in India

Avalon Consulting — Sun, 13 Jul 2025 06:38:55 +0000

Avalon Consulting worked with a top Fast-Moving Electrical Goods (FMEG) company in India, managing three major brands—one flagship and two acquired. Despite backend integration, the brands’ front-end operations led to overlaps, inefficiencies, and internal competition.

Avalon identified and addressed four synergy areas—product portfolio, marketing communication, sales organization, and distribution network. Our recommendations led to unified operations, stronger marketing impact, and better market penetration. The roadmap unlocked ₹1 Bn in EBITDA impact and ₹2.5 Bn in potential revenue synergies

Download Article [555 KB]

Taking too long?

Reload document

| Open in new tab

The post Impact Paper 31: Unlocking synergies for a leading FMEG company in India appeared first on Avalon Consulting.